The entity is usually triple-negative breast cancer (TNBC), which is negative for estrogen receptor (ER), progestogen receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression [2–29]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.